NASDAQ · SCTX
Scribe Therapeutics Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for SCTX: Dec 2, 2026
Scribe Therapeutics Inc. Common Stock is estimated to report earnings on 12/02/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.42.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.42 | $-0.42 | $-0.42 | 1 |
| Dec 2026 | $-0.40 | $-0.40 | $-0.40 | 1 |
| Mar 2027 | $-0.47 | $-0.47 | $-0.47 | 1 |
| Jun 2027 | $-0.55 | $-0.55 | $-0.55 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · RTTNews · BNK Invest- The Motley Fool · Oct 20, 12:50 PM EDTCathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtCathie Wood's Ark Invest bought shares of CoreWeave, Scribe Therapeutics, and Freenome on Monday.
- RTTNews · Sep 3, 3:48 AM EDTScribe Reports Narrower Loss In Q2 Due To Lower Expenses(RTTNews) – Scribe Therapeutics Inc. (SCTX) reported on Wednesday second quarter financial results, highlighting narrower net loss, due to lower expenses and a gain in the fair value of convertible notes. The company also provided corporate highlights and detailed upcoming milest
- RTTNews · Aug 21, 6:36 AM EDTBiotech Stocks At 52-Week Highs – SCTX Continues Rise After Nasdaq Debut, RPRX, HAE, TXG, LH(RTTNews) – The following biotech stocks reached a 52-week high on August 20, 2026, driven by key catalysts such as new product launches and the prospective release of data from clinical studies.
- RTTNews · Aug 20, 4:21 AM EDTBiotech Stocks At 52-Week Highs – MRNA Surges +176% On Phase 3 Data, SCTV, MRVI, SOPH, IMNM(RTTNews) – The following biotech stocks reached a 52-week high on August 19, 2026, primarily driven by positive clinical research results and promising quarterly reports.
- BNK Invest · Jul 28, 1:39 PM EDTTuesday 7/28 Insider Buying Report: KRNY, SCTXBargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we
- RTTNews · Jul 24, 1:17 AM EDTScribe Therapeutics Sets IPO Of 8.58 Mln Shares At $15/Shr; Enters Private Placement With Sanofi(RTTNews) – Scribe Therapeutics Inc. (SCTX), a clinical-stage biotechnology company, announced pricing of its upsized initial public offering of 8.58 million shares of its common stock at the high end of the range at a public offering price of $15 per share. In addition to the in
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Scribe Therapeutics Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.